Time Course of Immunosuppression Minimization and HLA Class I and Class II Antibody Emergence in Heart Transplantation

被引：0

作者：

Bakir, M. ^{[1
]}

Henriquez-Ticas, D. ^{[1
]}

Chang, E. ^{[1
]}

Maque, J. ^{[1
]}

Chittoor, J. ^{[1
]}

Starling, C. ^{[2
]}

Bondar, G. ^{[1
]}

Wisniewski, N. ^{[1
]}

Adigopula, S. ^{[1
]}

Khuu, T. ^{[1
]}

Reed, E. ^{[1
]}

Zhang, J. ^{[1
]}

Cadeiras, M. ^{[1
]}

Deng, M. ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Cardiol, Los Angeles, CA USA

[2] LMU, Cardiol, Los Angeles, CA USA

来源：

JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2015年 / 34卷 / 04期

关键词：

D O I：

10.1016/j.healun.2015.01.352

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

338

引用

页码：S131 / S132

页数：2

共 50 条

[1] Reduced HLA Class II antibody response to proteasome inhibition in heart transplantation
Khuu, Tam
Cadeiras, Martin
Wisniewski, Nicholas
Reed, Elaine F.
Deng, Mario C.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (06): : 863 - 865
[2] Differential Effect of Bortezomib on HLA Class I and Class II Antibody
Philogene, Mary Carmelle
Sikorski, Paul
Montgomery, Robert A.
Leffell, Mary S.
Zachary, Andrea A.
TRANSPLANTATION, 2014, 98 (06) : 660 - 665
[3] Molecular typing of HLA Class I and Class II for a transplantation programme
Bendukidze, N
Hána, I
Ivasková, E
BONE MARROW TRANSPLANTATION, 1998, 22 : S31 - S33
[4] The role of HLA class I and class II antibodies in renal transplantation
Iniotaki-Theodoraki, A
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 : 150 - 152
[5] Antibody verification of HLA class I and class II eplets by human monoclonal HLA antibodies
Kramer, Cynthia S. M.
Bezstarosti, Suzanne
Franke-van Dijk, Marry E. I.
Vergunst, Manon
Roelen, Dave L.
Uyar-Mercankaya, Merve
Voogt-Bakker, Kim H.
Heidt, Sebastiaan
HLA, 2024, 103 (01)
[6] Performance of the GTI Antibody Monitoring System: HLA Class I and Class II
Pressman, M
Chance, S
Adams, P
Orosz, C
Phelan, D
Mohanakumar, T
HUMAN IMMUNOLOGY, 2004, 65 : S113 - S113
[7] Predicting Emergence of Anti-HLA Class I and II Antibodies by Time Dependent Phenomapping in Heart Transplant Patients.
Bakir, M.
Jackson, N.
Chang, E.
Henriquez-Ticas, D.
Tseng, C. -H.
Khuu, T.
Zhang, J.
Reed, E.
Deng, M.
Cadeiras, M.
AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 551 - 551
[8] HLA Class II Mismatch Is Associated with Higher Incidence of Antibody Mediated Rejection after Heart Transplantation
Saidi, A.
Snow, G.
Brunisholz, K.
Hammond, E.
Wever-Pinzon, O.
Drakos, S.
Selzman, C.
Revelo, P.
Alharethi, R.
Miller, D.
Nativi-Nicolau, J.
Reid, B.
Budge, D.
Gilbert, E.
Kfoury, A.
Stehlik, J.
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 71 - 71
[9] SIGNIFICANT ANTIBODY REACTIVITY VARIATION OBSERVED ON HLA CLASS I AND CLASS II CONTROL ANTIBODIES
Du, Zeying
Marino, Susana
HUMAN IMMUNOLOGY, 2009, 70 : S15 - S15
[10] HLA class I and class II antigens in sarcoidosis
Morar, R.
Duarte, R.
Wadee, A. A.
Feldman, C.
SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2022, 112 (12): : 904 - 910

← 1 2 3 4 5 →